The global temperature-controlled packaging for pharmaceutical market is driven by various factors, such as the growing pharmaceutical industry, the increase in R&D investment, and the adoption of smarter cold chain technology. Moreover, scope in Asia-Pacific is an opportunity for the growth of the market. However, rise in raw material costs restrains the market growth.

The global temperature-controlled packaging for pharmaceutical market is expected to grow at 9.48% CAGR during the forecast period. In 2017, the market was led by North America, with a 40.52% share, followed by Asia-Pacific, and Europe with shares of 26.90% and 21.59%, respectively.
The temperature-controlled packaging for pharmaceutical market has been segmented based on product, type, temperature range, payload capacity, type of use, end-use industry, and region. By product, the market has been segmented as insulated shippers and insulated containers.

The insulated shippers segment accounted for the larger market share of 62.01% in 2017, with a market value of USD 3,172.3 million and is projected to register the highest CAGR of 9.26% during the forecast period. By type, active system segment accounted for the largest market share of 64.60% in 2017, with a market value of USD 3,304.7 million; projected to register the highest CAGR of 9.14% during the forecast period. By temperature range, the Up to 10?C segment accounted for the largest market share of 48.20% in 2017, with a market value of USD 2,466.1million; projected to witness the CAGR of 9.93% during the forecast period. Based on payload capacity, the Up to 10 L segment accounted for the market share of 30.11%, in 2017. On the other hand, among the type of use segments, single-use segment dominated the market, and accounted for market share of 81.71% in 2017. Pharmaceutical segment leads the market by end-use industry in 2017 with market value of USD 4,052.7 million, followed by clinical trials.